# Evaluation of the Haemostatic Agent Purabond in ENT TORS

> **NCT05405907** · — · COMPLETED · sponsor: **University Hospital Birmingham NHS Foundation Trust** · enrollment: 12 (actual)

## Conditions studied

- Hemorrhage

## Interventions

- **OTHER:** PuraBond haemostatic agent

## Key facts

- **NCT ID:** NCT05405907
- **Lead sponsor:** University Hospital Birmingham NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05405907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05405907, "Evaluation of the Haemostatic Agent Purabond in ENT TORS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05405907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*